High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors
{{custom_author.name}}, {{article.zuoZheEn}}
High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors
[{{custom_ref.label}}] |
{{custom_citation.content}}
|
/
〈 | 〉 |